Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 13 | 2017 | 1457 | 1.210 |
Why?
|
| Homeodomain Proteins | 6 | 2015 | 1124 | 1.060 |
Why?
|
| Prostatic Neoplasms | 9 | 2019 | 5860 | 0.450 |
Why?
|
| Cellular Reprogramming | 1 | 2015 | 202 | 0.420 |
Why?
|
| Nanog Homeobox Protein | 6 | 2015 | 63 | 0.390 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 2 | 2024 | 518 | 0.330 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 4 | 2018 | 466 | 0.330 |
Why?
|
| Androgens | 2 | 2016 | 508 | 0.330 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2015 | 2453 | 0.280 |
Why?
|
| Receptors, Androgen | 4 | 2019 | 854 | 0.270 |
Why?
|
| Hyaluronan Receptors | 4 | 2016 | 248 | 0.260 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 3346 | 0.240 |
Why?
|
| Adenosine Diphosphate | 1 | 2004 | 100 | 0.240 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2024 | 59 | 0.230 |
Why?
|
| Neoplasms | 5 | 2023 | 15919 | 0.230 |
Why?
|
| Arabidopsis | 1 | 2004 | 80 | 0.230 |
Why?
|
| Autocrine Communication | 1 | 2024 | 88 | 0.230 |
Why?
|
| Hydrazones | 1 | 2024 | 42 | 0.220 |
Why?
|
| Endosomes | 1 | 2024 | 105 | 0.220 |
Why?
|
| Cell Differentiation | 6 | 2019 | 4117 | 0.210 |
Why?
|
| Interferon Type I | 1 | 2024 | 282 | 0.210 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 587 | 0.200 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2024 | 218 | 0.200 |
Why?
|
| Mice, Inbred NOD | 5 | 2019 | 897 | 0.200 |
Why?
|
| Morpholines | 1 | 2024 | 296 | 0.200 |
Why?
|
| Cerebellar Diseases | 1 | 2023 | 91 | 0.200 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 178 | 0.200 |
Why?
|
| Animals | 24 | 2024 | 62045 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2023 | 1902 | 0.190 |
Why?
|
| Lysosomes | 1 | 2024 | 345 | 0.190 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 120 | 0.190 |
Why?
|
| Signal Transduction | 9 | 2024 | 12102 | 0.190 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 162 | 0.180 |
Why?
|
| Mice, SCID | 6 | 2019 | 1825 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 276 | 0.170 |
Why?
|
| Cell Line, Tumor | 11 | 2024 | 14838 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2019 | 9041 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 2 | 2024 | 1136 | 0.160 |
Why?
|
| MicroRNAs | 5 | 2016 | 2886 | 0.160 |
Why?
|
| Mice | 17 | 2024 | 35594 | 0.160 |
Why?
|
| Prostate | 2 | 2017 | 1089 | 0.150 |
Why?
|
| Embryoid Bodies | 1 | 2017 | 12 | 0.150 |
Why?
|
| Phenylthiohydantoin | 1 | 2018 | 104 | 0.150 |
Why?
|
| Endopeptidases | 1 | 2019 | 230 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2024 | 1366 | 0.140 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2017 | 111 | 0.140 |
Why?
|
| Fibroblast Growth Factors | 1 | 2017 | 257 | 0.130 |
Why?
|
| Cell Cycle | 1 | 2021 | 2137 | 0.120 |
Why?
|
| Phenotype | 6 | 2023 | 6516 | 0.120 |
Why?
|
| Epilepsy | 1 | 2023 | 947 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 1095 | 0.120 |
Why?
|
| Placenta | 1 | 2019 | 561 | 0.120 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2014 | 85 | 0.110 |
Why?
|
| Antigens, Differentiation | 2 | 2012 | 247 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 693 | 0.110 |
Why?
|
| Smad3 Protein | 1 | 2013 | 123 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 885 | 0.110 |
Why?
|
| Papilloma | 1 | 2013 | 86 | 0.110 |
Why?
|
| Mice, Knockout | 5 | 2024 | 5731 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2013 | 168 | 0.110 |
Why?
|
| Neoplasm Transplantation | 5 | 2016 | 1554 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 839 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 1503 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2015 | 6398 | 0.100 |
Why?
|
| Carcinogenesis | 2 | 2016 | 1033 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 2 | 2015 | 1029 | 0.100 |
Why?
|
| Carcinoma, Embryonal | 1 | 2011 | 31 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2024 | 3667 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2016 | 7237 | 0.090 |
Why?
|
| Lentivirus | 1 | 2011 | 164 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 1077 | 0.090 |
Why?
|
| Histones | 1 | 2017 | 1512 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3031 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 507 | 0.090 |
Why?
|
| Male | 17 | 2024 | 128374 | 0.080 |
Why?
|
| WW Domain-Containing Oxidoreductase | 2 | 2023 | 51 | 0.080 |
Why?
|
| Humans | 22 | 2024 | 270744 | 0.080 |
Why?
|
| Pseudogenes | 1 | 2009 | 91 | 0.080 |
Why?
|
| Keratin-5 | 1 | 2008 | 57 | 0.080 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 494 | 0.070 |
Why?
|
| Clone Cells | 1 | 2009 | 591 | 0.070 |
Why?
|
| Cell Line | 3 | 2023 | 5339 | 0.070 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 5149 | 0.070 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 271 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2008 | 565 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2024 | 3919 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2011 | 1164 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 3215 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 574 | 0.070 |
Why?
|
| Cellular Senescence | 1 | 2008 | 389 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 506 | 0.070 |
Why?
|
| Gastrointestinal Tract | 1 | 2008 | 324 | 0.060 |
Why?
|
| DNA Damage | 2 | 2024 | 1988 | 0.060 |
Why?
|
| Telomerase | 1 | 2008 | 547 | 0.060 |
Why?
|
| RNA Interference | 1 | 2009 | 1387 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2008 | 1875 | 0.060 |
Why?
|
| Castration | 2 | 2016 | 122 | 0.060 |
Why?
|
| Mitochondrial Membranes | 1 | 2024 | 59 | 0.060 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2024 | 45 | 0.060 |
Why?
|
| Electron Transport Complex I | 1 | 2024 | 67 | 0.060 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2013 | 1388 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 2196 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2024 | 322 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 6686 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2023 | 220 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 4223 | 0.050 |
Why?
|
| Stem Cells | 1 | 2008 | 1217 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 362 | 0.050 |
Why?
|
| Tongue | 2 | 2013 | 85 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 3341 | 0.050 |
Why?
|
| Arginine | 1 | 2023 | 508 | 0.040 |
Why?
|
| Protein Binding | 2 | 2019 | 3485 | 0.040 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2019 | 19 | 0.040 |
Why?
|
| Rats | 1 | 2009 | 6525 | 0.040 |
Why?
|
| Neoplasm Metastasis | 3 | 2021 | 5310 | 0.040 |
Why?
|
| DNA Replication | 1 | 2023 | 771 | 0.040 |
Why?
|
| Cell Survival | 2 | 2019 | 3063 | 0.040 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 25 | 0.040 |
Why?
|
| Ear, Inner | 1 | 2019 | 65 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 550 | 0.040 |
Why?
|
| Imidazoles | 1 | 2024 | 1064 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2019 | 225 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 294 | 0.040 |
Why?
|
| Cardiovascular System | 1 | 2019 | 142 | 0.040 |
Why?
|
| Mitochondria | 1 | 2024 | 1299 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2019 | 278 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 4889 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 344 | 0.030 |
Why?
|
| Cell Movement | 2 | 2013 | 2472 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 7383 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2023 | 1717 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5403 | 0.030 |
Why?
|
| Disease Management | 1 | 2021 | 1089 | 0.030 |
Why?
|
| Apoptosis | 3 | 2016 | 7754 | 0.030 |
Why?
|
| Kidney | 1 | 2024 | 2119 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 178 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 809 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2016 | 589 | 0.030 |
Why?
|
| Angiopoietins | 1 | 2013 | 35 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 739 | 0.030 |
Why?
|
| DNA Repair | 1 | 2021 | 1910 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 206 | 0.030 |
Why?
|
| Nitriles | 1 | 2018 | 939 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 7915 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1109 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 603 | 0.030 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2013 | 128 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2014 | 721 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2019 | 1038 | 0.030 |
Why?
|
| Benzamides | 1 | 2018 | 1879 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 7103 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 4875 | 0.030 |
Why?
|
| Asymmetric Cell Division | 1 | 2012 | 10 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2015 | 440 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2013 | 244 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 547 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1542 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2014 | 848 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 737 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2016 | 1726 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 387 | 0.020 |
Why?
|
| Epithelium | 1 | 2013 | 782 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 1028 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 3642 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2015 | 3656 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 1111 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2019 | 2651 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 3118 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2024 | 4795 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 5759 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2008 | 146 | 0.020 |
Why?
|
| Wound Healing | 1 | 2013 | 767 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2399 | 0.020 |
Why?
|
| Epidermis | 1 | 2008 | 196 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 3588 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 1442 | 0.020 |
Why?
|
| Skin | 1 | 2013 | 1273 | 0.020 |
Why?
|
| Biological Assay | 1 | 2009 | 178 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2016 | 2376 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 2008 | 242 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 4569 | 0.020 |
Why?
|
| Female | 4 | 2024 | 148945 | 0.020 |
Why?
|
| Cell Separation | 1 | 2009 | 610 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2014 | 1714 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 8124 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 13021 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 1960 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 4329 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 3604 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 14616 | 0.010 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 10706 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 22480 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 15911 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 2422 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 4134 | 0.010 |
Why?
|